Previous close | 22.80 |
Open | 23.00 |
Bid | 22.80 x N/A |
Ask | 23.20 x N/A |
Day's range | 22.80 - 23.00 |
52-week range | 19.70 - 25.60 |
Volume | |
Avg. volume | 1 |
Market cap | 5.07B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 28.86 |
EPS (TTM) | 0.79 |
Earnings date | 22 Feb 2024 |
Forward dividend & yield | 0.67 (2.94%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
Our writer details two FTSE 100 shares that she thinks could help build a great portfolio of stocks to boost long-term wealth. The post 2 FTSE 100 shares investors should consider buying for a winning portfolio appeared first on The Motley Fool UK.